Welcome to our dedicated page for Teekay Tankers SEC filings (Ticker: TNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Dry shipping jargon, volatile freight rates, and fleet revaluations can make Teekay Tankers’ disclosures feel as choppy as the open sea. Whether you are hunting for bunker-fuel cost sensitivity or tracking when captains in the C-suite buy shares, each form packs dense technical language that slows serious analysis.
Here’s the solution: Stock Titan’s AI reads every Teekay Tankers annual report 10-K simplified, every Teekay Tankers quarterly earnings report 10-Q filing, and every Teekay Tankers 8-K material events explained the moment they hit EDGAR. Our platform delivers AI-powered summaries that translate ballast-water retrofits, charter-hire receivables, and impairment triggers into clear highlights. Need Teekay Tankers insider trading Form 4 transactions or Teekay Tankers executive stock transactions Form 4 alerts? We stream those Form 4 insider transactions real-time so you can spot buying or selling before the market reacts.
Use these insights to compare TCE rates quarter over quarter, monitor debt-to-fleet value ratios, and confirm how board-approved dividends align with cash flows disclosed in the Teekay Tankers proxy statement executive compensation tables. From Teekay Tankers earnings report filing analysis to understanding Teekay Tankers SEC documents with AI, every section is linked, searchable, and updated instantly. No more scrolling through 200-page PDFs—just the data that matters, explained simply.
Paradigm BioCapital Advisors LP, its general partner, founder Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd. jointly filed a Schedule 13G reporting passive ownership of 1,128,613 Cidara Therapeutics (CDTX) common shares as of 23 Jul 2025.
This holding equals 5.6 % of the 20,163,696 shares outstanding (per the issuer’s 25 Jun 2025 prospectus supplement), crossing the 5 % threshold that mandates disclosure. The Cayman-based Fund directly owns 994,177 shares (4.9 %), with the balance held in separately managed accounts advised by Paradigm. All shares are subject to sole voting and dispositive power; no shared power is reported.
The stake is filed under Rule 13d-1(c); the certification states the securities were not acquired to influence or change control. Signatures were executed on 30 Jul 2025 by authorized signatory David K. Kim. No additional agreements, transactions, or control intentions are disclosed.